Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Fish and Richardson
Cantor Fitzgerald
Baxter
Cipla
McKesson

Generated: August 21, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,937,042

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,937,042
Title:Pharmaceutical compositions comprising GLP-1 peptides or extendin-4 and a basal insulin peptide
Abstract: Pharmaceutical composition for parenteral administration comprising a basal insulin peptide and an insulinotropic GLP-1 peptide comprising at least 6 zinc atoms per 6 insulin molecules.
Inventor(s): Plum; Anne (Birkerod, DK), Steensgaard; Dorte Bjerre (Copenhagen, DK), Thomsen; Jens Kaalby (Hellerup, DK), Schlein; Morten (Lyngby, DK), Markussen; Anne Sofie Kaj.ae butted.r (V.ae butted.rlose, DK), Poulsen; Christian (Copenhagen, DK)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:12/741,923
Patent Claim Types:
see list of patent claims
Composition; Dosage form;

Drugs Protected by US Patent 8,937,042

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Novo XULTOPHY 100/3.6 insulin degludec; liraglutide SOLUTION;SUBCUTANEOUS 208583-001 Nov 21, 2016 RX Yes Yes   Try a Free Trial   Try a Free Trial Y   Try a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,937,042

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
07120880Nov 16, 2007
PCT Information
PCT FiledNovember 14, 2008PCT Application Number:PCT/EP2008/065601
PCT Publication Date:May 22, 2009PCT Publication Number: WO2009/063072

International Family Members for US Patent 8,937,042

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Brazil PI0820535   Try a Free Trial
Canada 2705821   Try a Free Trial
China 101861333   Try a Free Trial
China 107115523   Try a Free Trial
China 107412742   Try a Free Trial
Denmark 2597103   Try a Free Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
QuintilesIMS
Medtronic
Farmers Insurance
McKesson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.